PDS Biotechnology Corp - Common (PDSB)

CUSIP: 70465T107

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / Common
Shares outstanding
49,594,356
Total 13F shares
5,489,394
Share change
-2,132,677
Total reported value
$16,083,121
Put/Call ratio
40%
Price per share
$2.93
Number of holders
73
Value change
-$6,957,012
Number of buys
39
Number of sells
42

Security key

70465T107

Report period

Q2 2024

Institutions

73

Top holders

10

Top shareholders of PDSB - PDS Biotechnology Corp - Common (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BlackRock Finance, Inc.
13F
Company
3.8%
1,867,427
$7,395,011 31 Mar 2024
13F
VANGUARD GROUP INC
13F
Company
3.2%
1,587,806
$6,287,711 31 Mar 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.3%
654,185
$2,590,887 31 Mar 2024
13F
STATE STREET CORP
13F
Company
1.1%
557,320
$2,206,987 31 Mar 2024
13F
INSPIRION WEALTH ADVISORS, LLC
13F
Company
0.72%
354,977
$1,405,709 31 Mar 2024
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.72%
354,800
$1,405,000 31 Mar 2024
13F
NORTHERN TRUST CORP
13F
Company
0.49%
241,231
$955,274 31 Mar 2024
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.38%
189,166
$749,097 31 Mar 2024
13F
Sofinnova Investments, Inc.
13F
Company
0.29%
142,635
$564,835 31 Mar 2024
13F
LPL Financial LLC
13F
Company
0.26%
128,465
$508,721 31 Mar 2024
13F
Nuveen Asset Management, LLC
13F
Company
0.22%
110,296
$436,772 31 Mar 2024
13F
Bank of New York Mellon Corp
13F
Company
0.2%
98,850
$391,446 31 Mar 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.18%
90,474
$358,277 31 Mar 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.17%
82,423
$326,394 31 Mar 2024
13F
COMMONWEALTH EQUITY SERVICES, LLC
13F
Company
0.16%
79,857
$316,000 31 Mar 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.16%
77,203
$305,724 31 Mar 2024
13F
JANE STREET GROUP, LLC
13F
Company
0.15%
75,279
$298,104 31 Mar 2024
13F
Iron Gate Global Advisors LLC
13F
Company
0.15%
75,016
$294,835 31 Mar 2024
13F
MORGAN STANLEY
13F
Company
0.15%
72,771
$288,172 31 Mar 2024
13F
XTX Topco Ltd
13F
Company
0.12%
60,254
$238,606 31 Mar 2024
13F
CITADEL ADVISORS LLC
13F
Company
0.1%
51,365
$203,405 31 Mar 2024
13F
UBS Group AG
13F
Company
0.09%
42,887
$169,833 31 Mar 2024
13F
MARSHALL WACE, LLP
13F
Company
0.08%
41,221
$163,235 31 Mar 2024
13F
BLAIR WILLIAM & CO/IL
13F
Company
0.08%
40,000
$158,400 31 Mar 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.08%
39,641
$156,978 31 Mar 2024
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.08%
37,840
$149,846 31 Mar 2024
13F
RHUMBLINE ADVISERS
13F
Company
0.07%
34,996
$138,576 31 Mar 2024
13F
Vontobel Holding Ltd.
13F
Company
0.06%
32,000
$126,720 31 Mar 2024
13F
GROUP ONE TRADING LLC
13F
Company
0.06%
30,456
$120,606 31 Mar 2024
13F
WOLVERINE TRADING, LLC
13F
Company
0.06%
29,602
$117,224 31 Mar 2024
13F
SIMPLEX TRADING, LLC
13F
Company
0.04%
21,653
$85,000 31 Mar 2024
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
0.04%
20,856
$82,590 31 Mar 2024
13F
BARCLAYS PLC
13F
Company
0.04%
19,766
$78,273 31 Mar 2024
13F
Invesco Ltd.
13F
Company
0.04%
18,529
$73,374 31 Mar 2024
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.04%
17,539
$70,000 31 Mar 2024
13F
Rathbones Group PLC
13F
Company
0.03%
15,800
$62,568 31 Mar 2024
13F
DEUTSCHE BANK AG\
13F
Company
0.03%
15,408
$61,016 31 Mar 2024
13F
Wealth Group, Ltd.
13F
Company
0.03%
15,399
$61,000 31 Mar 2024
13F
MetLife Investment Management, LLC
13F
Company
0.03%
15,026
$59,503 31 Mar 2024
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0.03%
14,123
$55,927 31 Mar 2024
13F
Marex Group plc
13F
Company
0.03%
14,000
$55,440 31 Mar 2024
13F
AMERICAN INTERNATIONAL GROUP, INC.
13F
Company
0.03%
13,952
$55,250 31 Mar 2024
13F
RAYMOND JAMES & ASSOCIATES
13F
Company
0.03%
13,852
$54,854 31 Mar 2024
13F
MERCER GLOBAL ADVISORS INC /ADV
13F
Company
0.03%
12,500
$50,000 31 Mar 2024
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.02%
12,134
$48,051 31 Mar 2024
13F
JPMORGAN CHASE & CO
13F
Company
0.02%
11,822
$46,814 31 Mar 2024
13F
LAZARI CAPITAL MANAGEMENT, INC.
13F
Company
0.02%
11,000
$43,560 31 Mar 2024
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.02%
10,489
$41,536 31 Mar 2024
13F
GSA CAPITAL PARTNERS LLP
13F
Company
0.02%
10,358
$41,000 31 Mar 2024
13F
EP Wealth Advisors, LLC
13F
Company
0.02%
10,207
$40,420 31 Mar 2024
13F

Institutional Holders of PDS Biotechnology Corp - Common (PDSB) as of Q2 2024

As of 30 Jun 2024, PDS Biotechnology Corp - Common (PDSB) was held by 73 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,489,394 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, INSPIRION WEALTH ADVISORS, LLC, GOLDMAN SACHS GROUP INC, NORTHERN TRUST CORP, Sofinnova Investments, Inc., SUSQUEHANNA INTERNATIONAL GROUP, LLP, and STATE STREET CORP. This page lists 75 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders
69
Q2 2024 holders
73
Holder diff
4
Investor Q1 2024 Shares Q2 2024 Shares Share Diff Share Chg % Q1 2024 Value $ Q2 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .